Table of Contents Table of Contents
Previous Page  14 / 114 Next Page
Information
Show Menu
Previous Page 14 / 114 Next Page
Page Background

14 The US-Israel Legal Review 2019

ISRAEL DESKS LEAGUE TABLES

well as for non-Israeli clients looking to expand

their presence in Israel. Active for more than 15

years, the team has recently acted for Japanese

computer manufacturing giant, Canon, in its

first ever acquisition in Israel – that of video

analysis company BriefCam Ltd. In addition to

such multinationals, the team also advises private

companies, investors, entrepreneurs, financial

institutions, and start-ups on M&A transactions,

joint ventures, strategic partnerships, public and

private offerings, litigation, international real

estate and patent and trademarks, emerging in first

place in the Israel Desks IP category.

It is particularly the high-tech sector in which

the team’s wealth of experience is best showcased.

Recently the team recently negotiated investment

agreements with several Israeli portfolio companies

in the agri-tech, fin-tech and ad-tech industries, and

also represents start-ups inobtaining funds. Publicly

listed software companies in Israel are among those

bene

fitting from its expertise in privacy and data

secu

rity in the US, the EU and beyond.

Visit

:

www.gtlaw.com/en/~/link.aspx?_id=1D98C1

4992

F445BAA7B8667C6F8D65A6&_z=z

HOGAN LOVELLS

Even before the official formation of the Israel

Practice Group in 2012, Hogan Lovells has been

involved in the Israeli market. With almost 3,000

lawyers across almost its global office network, the

group comprises Israeli Bar Association members,

citizens, and fluent Hebrew speakers. From life

sciences and energy, technology and healthcare,

Hogan Lovells helps companies to expand in Israel

or Israeli companies do more business abroad.

Recent highlights include the representation of

Teva Pharmaceutical Industries Ltd. In its USD 703

million sale of a portfolio of drugs for women to

European buyout firm, CVC Capital Partners.

The firm has a regulatory practitioner based in

Rehovot, who is dedicated to providing local and

real-time support for Israeli medical device and

life s

ciences companies seeking US Foo

d and Drug

Adm

inistration (FDA) approval.

Visit

:

www.hoganlovells.com/en/israel

HO

WARD KENNEDY

Howard Kennedy is recognized for its strong

track record of advising Israeli clients across real

estate, capital markets and private wealth. Clients

benefit from a presence on the ground in Israel,

via Laurence Begner, as well as the head of the

team, Charles Maxwell, who is based in London.

Supported by a network of strong connections, the

team offers clients a deep understanding of both

the Israel and UK markets.

In capital markets, the team helps clients raise

capital on AIM and the London Stock Exchange

Market and has also advised State of Israel Bonds in

the UK in relation to a range of regulatory matters.

Last year’s workload includes a string of high profile

com

mercial and residential acquisitions in the r

eal

estat

e sector, a key pillar of strength for the firm.

Visit

:

www.howardkennedy.com/international/

israe

l-team/

K&L GATES

With 27 of its 45 global offices involved in Israel-

related work, K&L Gates is a consistently high

performing operator in the Israeli market. Headed by

Clarissa Coleman in the London office, the Israel Desk

is prominent in the high-tech field, advising a number

of foreign venture capital and private equity funds,

from China, the US and Europe, on their investments

in the most cutting-edge Israeli tech companies,

as well as advising technology companies on their

international offerings. For example, the team

advised on the IPO of commercial drone company

ParaZero on the Australian Stock Exchange.

HighlyactiveintheVCspace,theteamrepresented

Israeli-Polish Venture Capital Fund, TDJ Pitango

Ventures on its investments in Cosmose, amarketing

technology company, as well as Neptune.ml, a US

developer of machine learning models, a deal which

involved the collaboration of the firm’s Warsaw

and Pittsburgh offices. The US ophthalmology-

focused venture capital fund, Visionary Ventures,

also instructed the firm with regards to its Series B

investment in Orasis Pharmaceuticals Ltd, an Israeli

clinical-stage pharmaceutical company. The Israel

Desk has also been involved in a raft of instructions

relating to intellectual property, commercial

disputes, consumer class actions and employment,

and the team has also represented Israeli public

real estate companies, such as Summit Real Estate

Holdi

ngs Ltd., in its acquisition of rea

l estate

prop

erties in Germany.

Visit

:

www.klgates.com/clarissa-coleman/